F5 CEO plans August sale of 1,300 shares under Rule 144

Rhea-AI Filing Summary

F5, Inc. (FFIV) – Form 144 filing: President & CEO François Locoh-Donou has notified the SEC of his intent to sell 1,300 common shares through Morgan Stanley on or about 1 Aug 2025. The shares have an estimated aggregate market value of $400,582, based on recent prices, and will trade on Nasdaq. F5 reports 57.43 million shares outstanding, so the proposed sale represents <0.01 % of the float.

The executive acquired the shares as restricted stock between 2020-2022. In the past three months he has already sold 2,600 shares in four transactions, generating gross proceeds of approximately $751,803. No indication of a 10b5-1 plan date is provided. The filing contains no operational or financial performance data; it is solely a notice of intended insider disposition under Rule 144.

While insider sales can be viewed cautiously, the dollar amount and percentage relative to total shares appear immaterial, suggesting limited direct impact on FFIV’s capital structure or daily trading liquidity.

Positive

• None.

Negative

• Continued insider selling: CEO has disposed of 2,600 shares in the past 3 months and plans to sell another 1,300, a potential weak sentiment signal.

Insights

Securities Analyst

TL;DR: CEO plans to sell 1,300 shares (<$0.5 M); size is immaterial and unlikely to move FFIV fundamentals.

The notice signals a routine liquidation of <0.01 % of outstanding equity, following modest sales earlier this summer. Aggregate past-quarter disposals equal 2,600 shares, or roughly $0.75 M. For a company with a ~$10 B market cap, this is de minimis. Absent accompanying financial disclosures, I view the filing as administratively neutral. The lack of a stated 10b5-1 plan date may raise minor governance questions, but liquidity and valuation implications are negligible.

Corporate Governance Expert

TL;DR: Insider selling is small but underscores need to track future trades for behavioral patterns.

Locoh-Donou’s cumulative 3-month sales total 3,900 shares (2,600 executed + 1,300 proposed). While percentages are low, repeated sales can influence sentiment if they persist. The absence of guidance on whether transactions are under a pre-established 10b5-1 plan limits transparency. Investors should monitor Form 4 filings to confirm execution and assess any emerging trend. From a governance lens, today’s filing alone is not impactful, but sequential activity could become a soft negative signal.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	1300	400582.00	57431570	08/01/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/01/2022	Restricted Stock	Issuer			760	11/01/2022	Not Applicable
Common	08/01/2022	Restricted Stock	Issuer			55	08/01/2022	Not Applicable
Common	11/01/2020	Restricted Stock	Issuer			485	11/01/2020	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
FRANCOIS LOCOH-DONOU 801 5TH AVENUE Seattle WA 98104	Common	07/01/2025	314	92416.48
FRANCOIS LOCOH-DONOU 801 5TH AVENUE Seattle WA 98104	Common	07/01/2025	986	290199.52
FRANCOIS LOCOH-DONOU 801 5TH AVENUE Seattle WA 98104	Common	06/02/2025	143	40610.57
FRANCOIS LOCOH-DONOU 801 5TH AVENUE Seattle WA 98104	Common	06/02/2025	1157	328576.43

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many F5 (FFIV) shares does the CEO plan to sell?

The Form 144 reports an intention to sell 1,300 common shares.

What is the estimated value of the proposed FFIV share sale?

The aggregate market value is approximately $400,582.

When is the proposed sale date for the FFIV shares?

The filing lists an approximate sale date of 01 Aug 2025.

How many FFIV shares has the CEO sold recently?

Over the past three months he sold 2,600 shares for roughly $751,803 in gross proceeds.

What percentage of F5’s outstanding shares does the 1,300-share sale represent?

Less than 0.01 % of the 57.43 million shares outstanding.

Does the filing mention a 10b5-1 trading plan?

No. The form provides no date of plan adoption or instruction, leaving that information unspecified.